Bromopyruvic acid
This active molecular is a synthetic brominated derivative of pyruvic acid which is a hexokinase II inhibitor and an effective antitumor agent because it is a highly reactive alkylating agent. The acute toxicity study provided an LD50 of 191.7 mg/kg for 3-BrPA in vivo. In 2010, Preclinical trials in Cancer in USA (Intra-arterial) for bromopyruvate was approved. In 2013, US FDA approved IND application for bromopyruvate in Liver cancer .
| Supplier | BOC Sciences |
|---|---|
| Product # | 1113-59-3 |
| Pricing | Inquire |
| Cas | 1113-59-3 |
| Molecular Weight | 166.96 |
| Molecular Formula | C3H3BrO3 |
| Canonical SMILES | C(C(=O)C(=O)O)Br |